The Global Hemoglobinopathy Treatment Drug Market is expected to grow with a CAGR of nearly 8% over the forecast period 2022-2028. Hemoglobinopathy is a group of hereditary blood disorders involving abnormalities in the structure of hemoglobin. These disorders include both sickle cell disease (SCD) and thalassemia. Common symptoms of this condition include severe pain, shortness […]
